Molecular and signaling mechanisms of atherosclerosis in insulin resistance

Eric A Schwartz1, Peter D Reaven

  • 1Division of Research, Carl T. Hayden VA Medical Center, 650 East Indian School Road, Phoenix, AZ 85012, USA.

Insights

Insulin resistance elevates cardiovascular risks due to activated cell signaling pathways. These pathways promote vascular inflammation and dysfunction, increasing atherosclerosis severity. Therapeutic strategies aim to mitigate this vascular damage.

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Molecular Biology

Background:

  • Insulin resistance is linked to increased cardiovascular complications.
  • The precise mechanisms underlying this association remain unclear.
  • Several factors elevated in insulin resistance may contribute.

Purpose of the Study:

  • To review key intracellular signal transduction pathways activated in insulin resistance.
  • To describe the damage induced by these activated pathways.
  • To discuss potential therapeutic interventions for vascular damage.

Main Methods:

  • Review of existing scientific literature on cell signaling in insulin resistance.
  • Analysis of pathways activated by hyperinsulinemia, hyperglycemia, and other metabolic factors.
  • Discussion of the interplay between these pathways and vascular health.

Main Results:

  • Hyperinsulinemia, hyperglycemia, and other factors inappropriately activate intracellular signaling.
  • Significant cross-talk occurs between these pathways, creating a pro-inflammatory cascade.
  • This cascade leads to vascular inflammation and cell dysfunction, enhancing atherosclerosis risk.

Conclusions:

  • Activated cell signaling pathways are central to the cardiovascular complications of insulin resistance.
  • Understanding these pathways offers targets for therapeutic intervention.
  • Limiting vascular damage is a key goal for managing insulin resistance-related cardiovascular disease.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
440
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.1K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
555
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.4K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.0K